AG-221-AML-004 (IDHENTIFY) (R/R)

AG-221-AML-004 (IDHENTIFY) (R/R)

A Phase 3, Multicenter, Open-label, Randomized Study Comparing the Efficacy and Safety of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects with Late Stage Acute Myeloid Leukemia  (AML) Harboring an Isocitrate Dehydrogenase 2 Mutation (IDHENTIFY)


Study treatments


Inclusion criteria


Exclusion criteria


Participating sites


Link